Skip to content

Evaluation of the citrulline generation test (CGT) using intravenous administration of glutamine-alanine in ICU patients with multiple organ dysfunction.

Evaluation of the citrulline generation test (CGT) using intravenous administration of glutamine-alanine in ICU patients with multiple organ dysfunction. - Small bowel function in MODS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33173
Enrollment
20
Registered
2009-03-24
Start date
2009-01-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiorgaan falen na sepsis, trauma, pancreatitis, shock, etc multiple organ dysfunction syndrome multiple organ failure

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age between 18-80 years;informed consent;The presence of multiple organ dysfunction syndrome (MODS), defined as more than 2 failing organs, irrespective of the aetiology (page 5, protocol)

Exclusion criteria

Exclusion criteria: *Documented causes of small bowel malabsorption possibly interfering with intestinal absorptive function, e.g. coeliac disease, Crohn*s disease of the small bowel, exocrine pancreatic insufficiency, radiation enteritis or short bowel syndrome. *Small intestinal resections and/or extensive colonic resection (> 2/3). *Liver cirrhosis Child-Pugh B or C, acute liver failure or renal failure requiring artificial support (e.g. CVVH). *Urea cycle defects/citrullinaemia. *Pregnancy (no long-term data are available on the effects of Dipeptiven* during pregnancy or lactation). *Use of (par)enteral medium chain triglycerides (MCT) or glutamine/citrulline supplements.

Design outcomes

Primary

MeasureTime frame
results of CGT testing: baseline citrulline levels, citrulline generation (AUC) after stimulation with intravenous glutamine sugar absorption testing to define intestinal permeability assessment of intestinal absorption using bombcalorimetry

Secondary

MeasureTime frame
comparison of primary parameters with nutritional indices and prognostic outcome parameters

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)